This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: The Institute of Cancer Research: Royal Cancer Hospital. Active years: 2022-2024.
Location History:
- Manchester, GB (2022 - 2024)
- Macclesfield, GB (2024)
Company Filing History:
Years Active: 2022-2024
Title: Mohammed Aljarah: Innovator in Cancer Treatment
Introduction
Mohammed Aljarah is a prominent inventor based in Manchester, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. With a total of 3 patents to his name, Aljarah is recognized for his work in the pharmaceutical industry.
Latest Patents
Aljarah's latest patents include groundbreaking inventions such as lysyl oxidase inhibitors. This invention relates to compounds that are useful as inhibitors of the lysyl oxidase (LOX) and lysyl oxidase-like (LOXL) family members. These compounds have potential applications in treating conditions mediated by LOX and LOXL, particularly in cancer therapies. One specific application involves the use of a LOX inhibitor for treating cancers associated with EGFR. Additionally, his research contemplates the identification of biomarkers that predict responsiveness to LOX inhibitors.
Another notable patent involves hexahydropyrrolo[3,4-c]pyrrole derivatives, which are pharmacologically effective as LOX inhibitors. These compounds are believed to be useful in cancer treatment, showcasing Aljarah's commitment to advancing medical science.
Career Highlights
Aljarah is affiliated with the Institute of Cancer Research, Royal Cancer Hospital, where he continues to push the boundaries of cancer research. His work is characterized by a focus on developing effective treatments that can significantly improve patient outcomes.
Collaborations
Aljarah collaborates with esteemed colleagues in his field, including Caroline Joy Springer and Dan Niculescu-Duvaz. These partnerships enhance the research efforts and contribute to the innovative solutions being developed at the Institute.
Conclusion
Mohammed Aljarah is a dedicated inventor whose work in cancer treatment is paving the way for new therapeutic options. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific advancements.